HGNC Family | Serpin peptidase inhibitors (SERPIN) |
Name | serpin peptidase inhibitor, clade C (antithrombin), member 1 |
Description | The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSERPINC1 encodes antithrombin—a member of the serpin family that plays a central role in the regulation of hemostasis. The mature protein functions as a potent inhibitor of key coagulation proteases by undergoing a dramatic conformational activation upon binding to glycosaminoglycans such as heparin. Structural studies have detailed how specific amino acid residues and hydrophobic interactions govern its high‐affinity binding to the heparin pentasaccharide, triggering the reactive center loop to reposition for optimal protease inhibition. Moreover, biochemical analyses have revealed that subtle structural alterations, including those leading to conformational polymerization, are critical determinants of its function and stability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nExtensive genetic investigations have demonstrated that diverse mutations in SERPINC1 underlie both quantitative (type I) and qualitative (type II) antithrombin deficiencies, which predispose to venous and, in some instances, arterial thrombotic events. In many patient cohorts, point mutations, small insertions/deletions, splice‐site changes and large genomic rearrangements have been characterized, revealing significant genotype–phenotype correlations. Certain variants—such as those affecting the heparin‐binding site—lead to aberrant conformational changes, increased polymerization, or altered secretion, thereby impairing the anticoagulant capacity of circulating antithrombin. These molecular defects correlate with variable clinical manifestations, ranging from early‐onset thrombotic episodes in children to subtler functional anomalies detectable only through comprehensive genetic screening."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "34"}, {"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central role in coagulation, antithrombin exhibits important anti‐inflammatory properties and modulates vascular as well as organ‐protective functions. Its actions extend to counteracting endotoxin‐induced hypotension, reducing ischemia/reperfusion injury in the liver and kidneys, and even contributing to the regulation of angiogenesis in cancer. These diverse clinical implications underscore why even subtle variations in SERPINC1 expression or structure may have significant pathophysiological outcomes. Understanding these multifaceted roles not only aids in risk stratification for thrombotic disorders but also opens avenues for therapeutic intervention across a spectrum of diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "35", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Masayuki Yamasaki, Wei Li, Daniel J D Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature07394"}], "href": "https://doi.org/10.1038/nature07394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18923394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18923394"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Beate Luxembourg, Daniel Delev, Christof Geisen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis of antithrombin deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH10-08-0538"}], "href": "https://doi.org/10.1160/TH10-08-0538"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21264449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21264449"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Daniel J D Johnson, Jonathan Langdown, Wei Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M607204200"}], "href": "https://doi.org/10.1074/jbc.M607204200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16973611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16973611"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zeyuan Lu, Feng Wang, Mingyu Liang "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SerpinC1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": "/Antithrombin III in kidney-related diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20160669"}], "href": "https://doi.org/10.1042/CS20160669"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28424376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28424376"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mohamad Aman Jairajpuri, Aiqin Lu, Umesh Desai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and its conformational activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M212319200"}], "href": "https://doi.org/10.1074/jbc.M212319200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12556442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12556442"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Veronique Picard, Marie-Dominique Dautzenberg, Bruno O Villoutreix, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2002-11-3391"}], "href": "https://doi.org/10.1182/blood-2002-11-3391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12595305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12595305"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Marco Guerrini, Sara Guglieri, Daniela Beccati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conformational transitions induced in heparin octasaccharides by binding with antithrombin III."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20060656"}], "href": "https://doi.org/10.1042/BJ20060656"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16796563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16796563"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Nethnapha Paredes, Aimin Wang, Leslie R Berry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M302895200"}], "href": "https://doi.org/10.1074/jbc.M302895200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12695507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12695507"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Michael Caspers, Anna Pavlova, Julia Driesen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH11-12-0875"}], "href": "https://doi.org/10.1160/TH11-12-0875"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22627591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22627591"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Javier Corral, David Hernandez-Espinosa, Jose Manual Soria, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-08-040774"}], "href": "https://doi.org/10.1182/blood-2006-08-040774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17244682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17244682"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Toshiyuki Miyata, Yukiko Sato, Junko Ishikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.thromres.2008.08.020"}], "href": "https://doi.org/10.1016/j.thromres.2008.08.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18954896"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18954896"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Javier Corral, María Eugenia de la Morena-Barrio, Vicente Vicente "}, {"type": "b", "children": [{"type": "t", "text": "The genetics of antithrombin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.thromres.2018.07.008"}], "href": "https://doi.org/10.1016/j.thromres.2018.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30005274"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30005274"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Feng Wang, Guangyuan Zhang, Zeyuan Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ki.2015.176"}], "href": "https://doi.org/10.1038/ki.2015.176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26108065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26108065"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "S Kuhle, D A Lane, K Jochmanns, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2001)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11686316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11686316"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Christian J Wiedermann "}, {"type": "b", "children": [{"type": "t", "text": "Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Care (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/cc4822"}], "href": "https://doi.org/10.1186/cc4822"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16542481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16542481"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "J Corral, J A Huntington, R González-Conejero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Thromb Haemost (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1538-7836.2004.00749.x"}], "href": "https://doi.org/10.1111/j.1538-7836.2004.00749.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15140129"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15140129"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Beate Luxembourg, Anna Pavlova, Christof Geisen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH13-05-0402"}], "href": "https://doi.org/10.1160/TH13-05-0402"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24196373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24196373"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Véronique Picard, Ulrike Nowak-Göttl, Christine Biron-Andreani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.9425"}], "href": "https://doi.org/10.1002/humu.9425"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16705712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16705712"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "R Gindele, Z Oláh, P Ilonczai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Thromb Haemost (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jth.13252"}], "href": "https://doi.org/10.1111/jth.13252"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26748602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26748602"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Elena Campello, Luca Spiezia, Claudia M Radu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH15-04-0286"}], "href": "https://doi.org/10.1160/TH15-04-0286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26354831"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26354831"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Julien Peltier, Jean-Pierre Roperch, Stéphane Audebert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Proteomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jprot.2016.07.031"}], "href": "https://doi.org/10.1016/j.jprot.2016.07.031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27492143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27492143"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "M E de la Morena-Barrio, I Martínez-Martínez, C de Cos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Thromb Haemost (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jth.13372"}], "href": "https://doi.org/10.1111/jth.13372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27214821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27214821"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "A Ordóñez, I Martínez-Martínez, F J Corrales, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of citrullination on the function and conformation of antithrombin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2009.07391.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2009.07391.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19843180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19843180"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "I-Chu Tseng, Feng-Pai Chou, Sheng-Feng Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00164.2008"}], "href": "https://doi.org/10.1152/ajpcell.00164.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18550704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18550704"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Irene Martínez-Martínez, José Navarro-Fernández, Alice Østergaard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-01-406207"}], "href": "https://doi.org/10.1182/blood-2012-01-406207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22498748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22498748"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Amal El Beshlawy, Ibrahim Alaraby, Heba Abou Hussein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Study of protein C, protein S, and antithrombin III in newborns with sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Crit Care Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PCC.0b013e3181c59032"}], "href": "https://doi.org/10.1097/PCC.0b013e3181c59032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19924026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19924026"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "René Mulder, F Nanne Croles, André B Mulder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SERPINC1 gene mutations in antithrombin deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Haematol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bjh.14658"}], "href": "https://doi.org/10.1111/bjh.14658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28317092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28317092"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Martine Alhenc-Gelas, Genevieve Plu-Bureau, Justine Hugon-Rodin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH16-08-0635"}], "href": "https://doi.org/10.1160/TH16-08-0635"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28300866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28300866"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ana I Antón, Raúl Teruel, Javier Corral, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Haematologica (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3324/haematol.2008.000604"}], "href": "https://doi.org/10.3324/haematol.2008.000604"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19229049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19229049"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ewa Wypasek, Javier Corral, Martine Alhenc-Gelas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pol Arch Intern Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.20452/pamw.4045"}], "href": "https://doi.org/10.20452/pamw.4045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28607330"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28607330"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "María Eugenia de la Morena-Barrio, Ana Isabel Antón, Irene Martínez-Martínez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH11-10-0701"}], "href": "https://doi.org/10.1160/TH11-10-0701"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22234719"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22234719"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Christelle Orlando, Olivier Heylen, Willy Lissens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.thromres.2015.03.013"}], "href": "https://doi.org/10.1016/j.thromres.2015.03.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25837307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25837307"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "N C Olson, L M Raffield, L A Lange, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Thromb Haemost (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jth.13899"}], "href": "https://doi.org/10.1111/jth.13899"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29112333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29112333"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "V Limperger, A Franke, G Kenet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical and laboratory characteristics of paediatric and adolescent index cases with venous thromboembolism and antithrombin deficiency. An observational multicentre cohort study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH14-02-0149"}], "href": "https://doi.org/10.1160/TH14-02-0149"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24966143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24966143"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sushmita Roy, S Andrew Josephson, Jane Fridlyand, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein biomarker identification in the CSF of patients with CNS lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2007.12.1053"}], "href": "https://doi.org/10.1200/JCO.2007.12.1053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18056677"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18056677"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Nicole C Kaneider, Ellen Förster, Birgit Mosheimer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH03-03-0184"}], "href": "https://doi.org/10.1160/TH03-03-0184"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14652650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14652650"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Gonzalo Izaguirre, Weiqing Zhang, Richard Swanson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M309266200"}], "href": "https://doi.org/10.1074/jbc.M309266200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14532267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14532267"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Hirotaka Isobe, Kenji Okajima, Mitsuhiro Uchiba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.v99.5.1638"}], "href": "https://doi.org/10.1182/blood.v99.5.1638"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11861278"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11861278"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Vanessa Roldán, Adriana Ordoñez, Francisco Marín, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2009)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19277409"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19277409"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Andra H James, Eleanor Rhee, Betty Thames, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of antithrombin levels in pregnancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.thromres.2014.07.025"}], "href": "https://doi.org/10.1016/j.thromres.2014.07.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25087890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25087890"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Naoaki Harada, Kenji Okajima, Mehtap Yuksel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Contribution of capsaicin-sensitive sensory neurons to antithrombin-induced reduction of ischemia/reperfusion-induced liver injury in rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thromb Haemost (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1160/TH04-02-0106"}], "href": "https://doi.org/10.1160/TH04-02-0106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15630490"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15630490"}]}]}]}
|
Synonyms | THPH7, AT3, ATIII-R2, ATIII, AT3D |
Proteins | ANT3_HUMAN |
NCBI Gene ID | 462 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
SERPINC1 has 6,373 functional associations with biological entities spanning 9 categories (molecular profile, organism, disease, phenotype or trait, functional term, phrase or reference, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 111 datasets.
Click the + buttons to view associations for SERPINC1 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SERPINC1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SERPINC1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SERPINC1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SERPINC1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SERPINC1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SERPINC1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SERPINC1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CCLE Cell Line Proteomics | Cell lines associated with SERPINC1 protein from the CCLE Cell Line Proteomics dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with SERPINC1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SERPINC1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of SERPINC1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SERPINC1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
ClinVar Gene-Phenotype Associations | phenotypes associated with SERPINC1 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SERPINC1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SERPINC1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SERPINC1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SERPINC1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of SERPINC1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with SERPINC1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with SERPINC1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with SERPINC1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SERPINC1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by SERPINC1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving SERPINC1 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving SERPINC1 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SERPINC1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SERPINC1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SERPINC1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with SERPINC1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with SERPINC1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for SERPINC1 protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SERPINC1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SERPINC1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of SERPINC1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SERPINC1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with SERPINC1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with SERPINC1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SERPINC1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with SERPINC1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SERPINC1 from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SERPINC1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GlyGen Glycosylated Proteins | ligands (chemical) binding SERPINC1 protein from the GlyGen Glycosylated Proteins dataset. | |
GO Biological Process Annotations 2015 | biological processes involving SERPINC1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing SERPINC1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing SERPINC1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing SERPINC1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by SERPINC1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by SERPINC1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by SERPINC1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx eQTL 2025 | SNPs regulating expression of SERPINC1 gene from the GTEx eQTL 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SERPINC1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SERPINC1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SERPINC1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SERPINC1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
GWASdb SNP-Disease Associations | diseases associated with SERPINC1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
GWASdb SNP-Phenotype Associations | phenotypes associated with SERPINC1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SERPINC1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HMDB Metabolites of Enzymes | interacting metabolites for SERPINC1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of SERPINC1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of SERPINC1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of SERPINC1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SERPINC1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
HPO Gene-Disease Associations | phenotypes associated with SERPINC1 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for SERPINC1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SERPINC1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for SERPINC1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SERPINC1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEGG Pathways | pathways involving SERPINC1 protein from the KEGG Pathways dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SERPINC1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SERPINC1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SERPINC1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SERPINC1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SERPINC1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing SERPINC1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SERPINC1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SERPINC1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SERPINC1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SERPINC1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Cancer Gene Co-expression Modules | co-expressed genes for SERPINC1 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SERPINC1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
NURSA Protein Complexes | protein complexs containing SERPINC1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
NURSA Protein-Protein Interactions | interacting proteins for SERPINC1 from the NURSA Protein-Protein Interactions dataset. | |
OMIM Gene-Disease Associations | phenotypes associated with SERPINC1 gene from the curated OMIM Gene-Disease Associations dataset. | |
PANTHER Pathways | pathways involving SERPINC1 protein from the PANTHER Pathways dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for SERPINC1 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SERPINC1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SERPINC1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving SERPINC1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving SERPINC1 protein from the Wikipathways PFOCR 2024 dataset. | |
PID Pathways | pathways involving SERPINC1 protein from the PID Pathways dataset. | |
Reactome Pathways 2014 | pathways involving SERPINC1 protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving SERPINC1 protein from the Reactome Pathways 2024 dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SERPINC1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SERPINC1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SERPINC1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SERPINC1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SERPINC1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SERPINC1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SERPINC1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SERPINC1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SERPINC1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SERPINC1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SERPINC1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SERPINC1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving SERPINC1 protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving SERPINC1 protein from the WikiPathways Pathways 2024 dataset. | |